Biotechnology
Officials from Novavax, Inc. , theState of Maryland andMontgomery County today celebrated the opening of Novavax's new state-of-the-art vaccine production facility at the company's headquarters inRockville, Maryland. The 5,000 square-foot, $5 million pil
03:03 May 1, 2008
Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that it will release financial results for the three months ended March 31, 2008 after market close on T
03:03 May 1, 2008
Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will participate in two upcoming conferences in May:
03:03 May 1, 2008
EUSA Pharma Inc , a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has divested its monoclonal antibody research business to the French company International Drug Development .
02:43 May 1, 2008
QUEBEC CITY, May 1 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. , a global biopharmaceutical company focused on endocrine therapy and oncology, will announce its first quarter 2008 financial and operating results before market open on Wednesday, May 7,
02:33 May 1, 2008
Icagen, Inc. today announced it will release first quarter 2008 financial results on Thursday, May 8, 2008. The Company will also conduct a conference call that day at 10:00 a.m. Eastern Time to discuss results and highlights of the first quarter 2008.
02:31 May 1, 2008
Targeted Genetics Corporation will report its first quarter 2008 financial results before the open of the financial markets on Wednesday, May 7, 2008. Following the announcement, management will host a conference call and webcast discussion of the financ
02:30 May 1, 2008
Interleukin Genetics, Inc. , today announced publication of the results of clinical studies that support the company's Heart Health Genetic Test to assess cardiovascular risk. The article, titled, "IL1B Gene Promoter Haplotype Pairs Predict Clinical
02:03 May 1, 2008
West Pharmaceutical Services, Inc. today announced results for the first quarter of 2008. Reported results included net after-tax benefits of $1.3 million, or $0.04 per diluted share, representing the combined effects of restructuring charges, a contract
02:03 May 1, 2008
Osteotech, Inc. , a leader in the emerging field of biological products for regenerative healing, announced today that revenue for the first quarter of 2008 increased 10% to $27.6 million from $25.2 million for the first quarter of 2007. Revenue from the
02:03 May 1, 2008
Vanda Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced financial and operational results for the first quarter e
02:03 May 1, 2008
Orchid Cellmark Inc. , a leading worldwide provider of identity DNA testing services, will release its first quarter 2008 financial results on Thursday, May 8, 2008 at approximately 7:00 a.m. EDT, and is hosting a conference call and webcast to discuss t
02:03 May 1, 2008
United Therapeutics Corporation today announced its results of operations for the quarter ended March 31, 2008.
02:03 May 1, 2008
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2008.
02:03 May 1, 2008
Favrille, Inc. , a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced today that it will host a conference call and live webcast at 5:00 p.m. Eastern Time on Thursday, May 8, 2008 to discu
02:03 May 1, 2008
Anesiva, Inc. today announced the expansion of the company's license and distribution agreement for Zingo with Sigma-Tau SpA to include additional European countries. Zingo powder intradermal injection system is approved inthe United States to provide to
02:03 May 1, 2008
Anesiva, Inc. will announce financial results for the first quarter of 2008 after the markets close on Thursday, May 8, 2008 and will hold a webcast teleconference at 4:30 p.m. EDT that day. Members of Anesiva's management team will discuss financial res
02:03 May 1, 2008
LYDALL, INC. today announced financial results for the first quarter ended March 31, 2008.
02:00 May 1, 2008
A Phase I clinical trial, using a DUSA Pharmaceuticals, Inc. product, has been launched by the National Cancer Institute to study an entirely new approach for the prevention of oral cancer, which may affect more than 30,000 Americans this year. Chronic m
01:34 May 1, 2008
Vical Incorporated today announced that the company will report financial results for the quarter ended March 31, 2008, before the opening of trading on Thursday, May 8, and conduct a conference call and webcast to discuss the financial results and provi
01:33 May 1, 2008
44977 - 44996 of 48576 Stories
<<
<
Next 20 Biotechnology
>
>>
Search News
Daily News
